tm
Seeing Is Believing
tm
Seeing Is Believing
MRNS is currently covered by 9 analysts
Marinus Pharmaceuticals's activity chart (see below) currently has 46 price targets and 72 ratings on display. The stock rating distribution of MRNS is 92.86% BUY and 7.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.6% with an average time for these price targets to be met of 44.43 days.
Highest price target for MRNS is $10, Lowest price target is $1.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 24-Sep-2024.
Currently out of the existing stock ratings of MRNS, 39 are a BUY (92.86%), 3 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13
$11.15 (602.70%)
$13
1 years 9 months 15 days ago
(24-Sep-2024)
0/7 (0%)
$11.1 (584.21%)
Hold
$6
$4.15 (224.32%)
$9
1 years 9 months 16 days ago
(23-Sep-2024)
1/6 (16.67%)
$4.31 (255.03%)
5
Buy
$13
1 years 10 months 25 days ago
(14-Aug-2024)
1/6 (16.67%)
$6.1 (88.41%)
309
Buy
$11
$9.15 (494.59%)
$11
1 years 10 months 25 days ago
(14-Aug-2024)
0/15 (0%)
$9.9 (900.00%)
Buy
$3
$1.15 (62.16%)
$21
2 years 2 months 24 days ago
(15-Apr-2024)
2/10 (20%)
$1.7 (130.77%)
247
What is MRNS (Marinus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MRNS (Marinus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most bullish on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most reserved on MRNS (Marinus Pharmaceuticals)?
